Minireviews
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Dec 26, 2021; 9(36): 11148-11155
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11148
Stem cell therapy: A promising treatment for COVID-19
Zhi-Xue Zheng
Zhi-Xue Zheng, Department of General Surgery, Beijing Jishuitan Hospital, Beijing 100035, China
Author contributions: Zheng ZX contributed to writing the manuscript, drafting conception and design.
Conflict-of-interest statement: The author declared there are no conflicts of interest to this work.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhi-Xue Zheng, MD, Doctor, Surgeon, Surgical Oncologist, Department of General Surgery, Beijing Jishuitan Hospital, No. 31 Xinjiekou East Street, Beijing 100035, China. pollitzheng@sina.com
Received: March 26, 2021
Peer-review started: March 26, 2021
First decision: May 12, 2021
Revised: May 12, 2021
Accepted: August 23, 2021
Article in press: August 23, 2021
Published online: December 26, 2021
Processing time: 272 Days and 0.2 Hours
Core Tip

Core tip: Coronavirus disease 2019 (COVID-19) has become a global pandemic and entered an emergency phase. However, there are still no specific effective drugs for the COVID-19. Many previous studies have shown that mesenchymal stem cell transplantation is a promising choice for COVID-19-infected patients, and further studies need to be done in the future.